Selective cyclooxygenase 2 inhibitors and cardiovascular events.
Solomon
Daniel H
DH
Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02120, USA. dhsolomon@partners.org
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002319:Cardiovascular System / Q000187:drug effects* / Q000473:pathology; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000473:pathology; D020521:Stroke / Q000139:chemically induced* / Q000473:pathology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors